ArticleInflammopharmacology2026
Anti-osteoarthritic effects of stem bark extract of Anogeissus latifolia: a comprehensive in-vivo study.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnogeissus latifolia Roxb. (Family: Combretaceae) is an Indian medicinal plant. The bark of the plant is used traditionally in the Ayurvedic system of medicine for the treatment of pain, inflammation, and arthritis. The objective of this study was to investigate the protective effects of ethanol extract of the stem bark of Anogeissus latifolia Roxb. (EAL) in osteoarthritis-induced rats, to verify its use in traditional medicine and contribute to the understanding of its ethnopharmacological importance.
methodsOsteoarthritis was induced by injecting 3 mg of monosodium iodoacetate (MIA) into the knee joint under anesthesia. The anti-osteoarthritic activity of EAL was investigated at 100, 200 and 400 mg/kg oral doses for 28 days by estimating joint swelling, the weight-bearing capacity of joints, locomotor activity, and serum levels of inflammatory markers such as IL-6, IL-1β, TNF-α, MMP-1 and MMP-13. Histopathology and radiological examinations of the knee joints were performed.
resultsTreatment with EAL resulted in a marginal, statistically nonsignificant reduction in arthritis-induced joint swelling. The weight-bearing capacity of joints and locomotor activity were improved significantly by the EAL. There was a significant decrease in serum IL-6, IL-1β, TNF-α, MMP-1 and MMP-13 levels in EAL-treated rats. Arthritis-induced pathological changes in the knee joints were reversed by the EAL.
conclusionsThe ethanolic stem bark extract of Anogeissus latifolia exhibited anti-osteoarthritic activity in the MIA-induced rat model, potentially mediated through modulation of inflammatory mediators and cytokines.
Indexed as
Identifiers
41579316What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.